Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian E Smith

Showing results (71-80 of 132) with videos related to

Pageof 14
Sort By:
Breast Cancer Research and Treatment|November 5, 2014
Differences in expression of proliferation-associated genes and RANKL across the menstrual cycle in estrogen receptor-positive primary breast cancerBen P Haynes, Giuseppe Viale, Viviana Galimberti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2008
The effects of neoadjuvant anastrozole and tamoxifen on circulating vascular endothelial growth factor and soluble vascular endothelial growth factor receptor 1 in breast cancerSusana Banerjee, Sunil Pancholi, Roger A'hern, et al.
Psychopharmacology|August 7, 2010
Clinical and neurocognitive changes with modafinil in obsessive-compulsive disorder: a case reportWinand H Dittrich, Thomas Johansen, Ashwini K Padhi, et al.
Journal of Psychopharmacology (Oxford, England)|November 8, 2005
Chronic treatment with modafinil may not be beneficial in patients with chronic fatigue syndromeDelia C Randall, Fay H Cafferty, John M Shneerson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
Integration of signal transduction inhibitors with endocrine therapy: an approach to overcoming hormone resistance in breast cancerStephen R D Johnston, Julia Head, Sunil Pancholi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2006
Adjuvant aromatase inhibitors for early breast cancer after chemotherapy-induced amenorrhoea: caution and suggested guidelinesIan E Smith, Mitch Dowsett, Yoon-Sim Yap, et al.
Breast Cancer Research and Treatment|February 5, 2013
Expression of key oestrogen-regulated genes differs substantially across the menstrual cycle in oestrogen receptor-positive primary breast cancerBen P Haynes, Giuseppe Viale, Viviana Galimberti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2010
Intratumoral estrogen disposition in breast cancerBen P Haynes, Anne Hege Straume, Jürgen Geisler, et al.
Steroids|March 31, 2011
Association between breast cancer subtypes and response to neoadjuvant anastrozoleAnita K Dunbier, Helen Anderson, Zara Ghazoui, et al.
Breast Cancer Research and Treatment|February 28, 2009
Relationship between oestrogen receptor status and proliferation in predicting response and long-term outcome to neoadjuvant chemotherapy for breast cancerRobin L Jones, Janine Salter, Roger A'Hern, et al.
Pageof 14

Showing results (71-80 of 132) with videos related to

Sort By:
Pageof 14
Breast Cancer Research and Treatment|November 5, 2014
Differences in expression of proliferation-associated genes and RANKL across the menstrual cycle in estrogen receptor-positive primary breast cancerBen P Haynes, Giuseppe Viale, Viviana Galimberti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 3, 2008
The effects of neoadjuvant anastrozole and tamoxifen on circulating vascular endothelial growth factor and soluble vascular endothelial growth factor receptor 1 in breast cancerSusana Banerjee, Sunil Pancholi, Roger A'hern, et al.
Psychopharmacology|August 7, 2010
Clinical and neurocognitive changes with modafinil in obsessive-compulsive disorder: a case reportWinand H Dittrich, Thomas Johansen, Ashwini K Padhi, et al.
Journal of Psychopharmacology (Oxford, England)|November 8, 2005
Chronic treatment with modafinil may not be beneficial in patients with chronic fatigue syndromeDelia C Randall, Fay H Cafferty, John M Shneerson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 23, 2003
Integration of signal transduction inhibitors with endocrine therapy: an approach to overcoming hormone resistance in breast cancerStephen R D Johnston, Julia Head, Sunil Pancholi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 2006
Adjuvant aromatase inhibitors for early breast cancer after chemotherapy-induced amenorrhoea: caution and suggested guidelinesIan E Smith, Mitch Dowsett, Yoon-Sim Yap, et al.
Breast Cancer Research and Treatment|February 5, 2013
Expression of key oestrogen-regulated genes differs substantially across the menstrual cycle in oestrogen receptor-positive primary breast cancerBen P Haynes, Giuseppe Viale, Viviana Galimberti, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 11, 2010
Intratumoral estrogen disposition in breast cancerBen P Haynes, Anne Hege Straume, Jürgen Geisler, et al.
Steroids|March 31, 2011
Association between breast cancer subtypes and response to neoadjuvant anastrozoleAnita K Dunbier, Helen Anderson, Zara Ghazoui, et al.
Breast Cancer Research and Treatment|February 28, 2009
Relationship between oestrogen receptor status and proliferation in predicting response and long-term outcome to neoadjuvant chemotherapy for breast cancerRobin L Jones, Janine Salter, Roger A'Hern, et al.
Pageof 14